Condition: Multiple Sclerosis Spasticity · Sponsor: Celgene
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Alabama Neurology Associates | Birmingham, Alabama, United States | Recruiting |
| Perseverance Research Center,LLC | Scottsdale, Arizona, United States | Recruiting |
| Local Institution - 0017 | Aurora, Colorado, United States | Withdrawn |
| Aqualane Clinical Research | Naples, Florida, United States | Recruiting |
| USF Health | Tampa, Florida, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Neurology Center of New England | Foxborough, Massachusetts, United States | Recruiting |
| Local Institution - 0071 | Southfield, Michigan, United States | Not Yet Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| University of Cincinnati Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Riverside Methodist Hospital | Columbus, Ohio, United States | Recruiting |
| Local Institution - 0069 | Columbus, Ohio, United States | Withdrawn |
+ 42 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06782490